Platelets and coronary heart disease: potential psychophysiologic mechanisms

J H Markovitz1, K A Matthews

  • 1Department of Psychiatry, University of Pittsburgh, PA 15213.

Psychosomatic Medicine
|November 1, 1991
PubMed

Insights

Psychological stress may increase platelet reactivity, a key factor in blood clot formation. This heightened platelet activity is a potential mechanism linking emotional stress to acute coronary events like heart attacks.

Area of Science:

  • Cardiology
  • Psychophysiology
  • Hematology

Background:

  • Coronary heart disease (CHD) risk is linked to psychophysiological factors, but mechanisms are underexplored.
  • Thrombosis, driven by platelet activation, precipitates acute coronary events.
  • Platelet inhibition is a proven strategy for preventing coronary events.

Purpose of the Study:

  • To review platelet physiology and pathophysiology.
  • To discuss platelet function testing and its clinical role in atherosclerosis and acute coronary events.
  • To propose platelet reactivity to psychological stress as a major mechanism in coronary events.

Main Methods:

  • Literature review of platelet physiology, pathophysiology, and activation.
  • Discussion of platelet function testing methodologies.
  • Analysis of existing research on stress and platelet activity.

Main Results:

  • Platelet activation is a critical component of arterial thrombosis and acute coronary events.
  • Epinephrine and shear stress are significant clinical platelet activators.
  • Existing literature supports the hypothesis that emotional stress increases platelet activity.

Conclusions:

  • Platelet reactivity to psychological stress is a plausible and significant mechanism contributing to coronary events.
  • Further research is needed to fully elucidate the link between emotional stress, platelet activity, and cardiovascular risk.

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...